The U.S. Vaccine Supply

To the Editor: The National Vaccine Advisory Committee, of which I am a member, agrees with the Institute of Medicine (IOM) vaccine-financing committee 1 that legislative measures and additional funding are needed, but we differ with its recommendations for action, as described by Sloan et al. (Dec....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2005-03, Vol.352 (10), p.1046-1047
1. Verfasser: Hinman, Alan R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To the Editor: The National Vaccine Advisory Committee, of which I am a member, agrees with the Institute of Medicine (IOM) vaccine-financing committee 1 that legislative measures and additional funding are needed, but we differ with its recommendations for action, as described by Sloan et al. (Dec. 2 issue). 2 At the request of the IOM committee, the National Vaccine Advisory Committee convened stakeholder deliberations on vaccine-financing options and concluded that it is not advisable to replace the current system with an insurance mandate and a system of subsidies and vouchers, as the IOM recommends. We are skeptical that such a system . . .
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM200503103521020